We have located links that may give you full text access.
Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis.
Chest 1994 Februrary
OBJECTIVE: To determine whether mitral valve or anulus calcification (MC) in patients with end-stage renal disease is associated with abnormalities of left ventricular (LV) structure and function, cardiac characteristics of 55 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) with (n = 26; age: 59 +/- 10 years) vs without (n = 29; age: 58 +/- 12 years) MC were analyzed using echocardiography and Doppler echocardiography. Sclerosis of the mitral valve anulus was detected in 18 (7 women, 11 men; age: 58 +/- 10 years) patients, sclerosis of mitral valve leaflets in 24 (13 women, 9 men; age: 59 +/- 10 years) patients. Patients with MC had higher systolic arterial blood pressure before initiation of dialysis therapy (191/104 mm Hg vs 173/94 mm Hg; p < 0.05) and higher calcium-phosphorus products (55 +/- 13 vs 42 +/- 16; p < 0.05) during CAPD therapy than those without MC. Neither prevalence nor severity of MC was related to dialysis duration or patient age. Systolic LV function was reduced (ejection fraction: 58 +/- 12 percent vs 65 +/- 13 percent; p < 0.05) and LV end-diastolic diameters were dilated (54 +/- 5 vs 50 +/- 8 mm; p < 0.05) in patients with MC. Left atrial dilatation (73 percent vs 31 percent; p < 0.005) and mitral valve regurgitation (65 percent vs 21 percent; p < 0.001) were more frequent in patients with vs those without MC. Excluding patients with significant mitral regurgitation from pulsed Doppler analysis, diastolic LV function was comparably impaired in patients with vs those without MC (maximal early/atrial filling velocity ratio: 0.77 +/- 0.25 vs 0.75 +/- 0.22; atrial filling fraction: 47 +/- 10 percent vs 48 +/- 11 percent; p = NS). The presented data suggest that MC follows long-standing and severe arterial hypertension before start of dialysis therapy. Therefore, effective blood pressure control in the predialysis period may be a tool to prevent these lesions. MC has clinical significance as a marker of LV dilatation and reduced LV systolic function in patients with chronic CAPD.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app